The technology is compatible with all PTFE grafts and was studied extensively in the company's pivotal clinical trial...
Revenue up 5.8 per cent to HK$876.5 million, Profit up 3.8 per cent to HK$163.4 million...
The RAD Temp ensures uninterrupted cancer treatment in Northeast Texas as TRMC upgrades its vault and linear accelerator for more precise, advanced care....
Lumipulse pTau-217/Beta Amyloid 42 ratio now available nationwide through Labcorp...
Quarterly rehab program now welcomes Parkinson’s patients, offering intensive therapy with NeuFit’s NEUBIE device....
Trial to assess Calibreye™ Titratable Glaucoma Therapy™ Surgical System in refractory glaucoma patients ...
CEO Lawrence Florin discusses how human-relevant organ-on-a-chip systems and continuously updated digital twins are improving translational accuracy, reducing reliance on animal testing, and opening new frontiers in precision medicine....
